ABSTRACT
Recent studies in mouse models have established an important role for CD4 + and CD8 + TRM in mediating protective immunity to diverse pathogens 2, [5] [6] [7] . Defining how tissue site impacts T cell function is therefore important for targeting T cell immunity.
In humans, most of our knowledge of T cell activation and function derives from the sampling of peripheral blood. Recent studies in human tissues have revealed that the majority of human T cells are localized in lymphoid mucosal and barrier tissues 8 and that T cell subset composition is a function of the specific tissue site 9, 10 . Human TRM cells can be defined based on their phenotypic homology to mouse TRM and are distinguished from circulating T cells in blood and tissues by a core transcriptional and protein signature [10] [11] [12] [13] . However, the role of tissue site in determining T cell functional responses, and a deeper understanding of the relationship between blood and tissue T cells beyond composition differences are key unanswered questions in human immunology.
The functional responses of T cells following antigen or pathogen exposure have been largely defined in mouse models, and are generally classified based on whether or not they 4 secrete specific cytokines or effector molecules. Effector CD4 T cells comprise different functional subtypes (Th1 cells secrete IFN-γ and IL-2; Th2 secrete IL-4, 13; Th17 secrete IL-17, etc.) 14 , while effector CD8 T cells secrete pro-inflammatory cytokines (IFN-γ,TNF-α) and/or cytotoxic mediators (perforin and granzymes) 15 . Certain conditions can lead to inhibition of functional responses; for example, CD4 + T cells encountering self-antigen become anergic and fail to produce IL-2, while CD8 + T cells responding to chronic infection, tumors, or lacking CD4 + T cell help become functionally exhausted, and express multiple inhibitory molecules (e.g., PD-1, LAG3) [16] [17] [18] . While human T cells can produce similar cytokines, effector and inhibitory molecules as mouse counterparts [19] [20] [21] [22] , the full complement of functional responses for human T cells in tissues has not been elucidated. Establishing a comprehensive baseline of healthy T cell states in humans is essential for defining dysregulated and pathological functions of T cells in disease.
Single cell transcriptome profiling (scRNA-seq) has enabled high resolution mapping of cellular heterogeneity, development, and activation states in diverse systems 23, 24 . This approach has been applied to analyze human T cells in diseased tissues 25, 26 and in response to immunotherapies in cancer 27 ; however, the baseline functional profiles of human T cells in healthy blood and tissues have not been defined. We have established a tissue resource where we obtain multiple lymphoid, mucosal, and other peripheral tissue sites from human organ donors [9] [10] [11] 13, 28, 29 , enabling study of T cells across different anatomical spaces. Here, we used scRNA-seq of over 50,000 resting and activated T cells from lung (LG), lymph nodes (LN), bone marrow (BM) and blood, along with innovative computational analysis to define cellular states of homeostasis and activation of human blood and tissue-derived T cells. We reveal how human T cells in tissues relate to those in blood, and identify a conserved tissue signature and activation states for human CD4 + and CD8 + T cells conserved across all sites. We further show how scRNA-seq profiles of T cells associated with 5 human tumors can be projected onto this healthy baseline dataset, revealing their functional state.
Our results establish a comprehensive high dimensional dataset of human T cell homeostasis and function in multiple sites, from which to define the origin, composition and function of T cells in disease.
6
RESULTS

High Resolution analysis of human T cells in tissues and comparison to blood
We obtained BM, LN, and LG as representative primary lymphoid, secondary lymphoid and mucosal tissue sites, respectively, from two adult organ donors who met the criteria of health for donation of physiologically healthy tissues for lifesaving transplantation, being free of chronic disease, cancer, and infections (Supplementary Table 1 ). For comparison, we obtained blood from two healthy adult volunteers. CD3 + T cells isolated from tissues and blood were cultured in media alone ("resting") or in the presence of anti-CD3/anti-CD28 antibodies ("activated") ( Fig. 1a) . Single cells were encapsulated for cDNA synthesis and barcoding using the 10x Genomics Chromium system, followed by library construction, sequencing, and computational identification of T cells ( Supplementary Fig. 1 , Supplementary Tables 2,3) .
We initially analyzed tissue T cell populations from the two individual donors, comprising six samples per donor (resting and activated samples from three tissue sites). We merged all data for each donor, performed unsupervised community detection 30 to cluster the data based on highly-variable genes (Supplementary Table 4) , and projected cells in two dimensions using Uniform Manifold Approximation and Projection (UMAP) 31 . For both donors, the dominant sources of variation between cells were activation state (vertical axis) and CD4/CD8 lineage (horizontal axis) (Fig. 1b) . Tissue site was also a source of variability; T cells from BM and LN co-clustered while LG T cells were more distinct (Fig. 1b) , consistent with T cell subset composition differences in these sites from phenotype analysis (Supplementary Figure 2 and previous studies 10, 13, 32 Supplementary Fig. 2) ; the remaining resting and activated CD4 + and CD8 + clusters derived from all sites (Fig. 1b,c) . These results show subset-specific profiles in human tissues, but suggest similar 13 activation profiles across sites.
To assess how blood T cells relate to those in tissue, we performed scRNA-seq analysis of resting and activated blood T cells from two adult donors, and projected the merged data onto the UMAP embeddings of T cells from each tissue donor (Fig. 2a,b , Online Methods). The majority of blood T cells co-localized with resting or activated T cells from BM but did not exhibit substantial overlap with LG or LN T cells from either donor, particularly in the resting state ( Fig. 2a,b) . We also quantified the number of blood T cells that were transcriptionally similar to CD4 + and CD8 + T cells from each tissue within resting or activated samples (Fig. 2c,d , Online Methods). Resting blood T cells were highly represented among CD4 + and CD8 + T cells in BM (Fig. 2c, d ). Interestingly, a substantial number of unstimulated blood T cells projected 8 onto activated CD4 + T cells in BM for both donors (Fig. 2c,d , left panels). In contrast, activated blood T cells were strongly represented among activated CD4 + T cells for all tissue sites and in LN for CD8 + T cells ( Fig. 2c,d ; right panels). Consistent results were obtained analyzing each blood sample separately ( Supplementary Fig. 3 ). These results suggest that blood T cells are fundamentally distinct from tissue T cells and may persist in a more activated basal state than in tissues, while activated blood and tissue-derived T cells share common signatures.
A universal gene signature distinguishes tissue T cells from blood
The major transcriptional differences between tissue and blood T cells based on population RNAseq originate from the presence of TRM in tissues 13 . Because scRNA-seq enables high resolution detection of gene expression differences that can be unambiguously traced to specific T cells, we investigated whether there were intrinsic features of tissue T cells that distinguished them from blood. Resting memory T cells in tissues and blood express high levels of CCL5 ( Supplementary Fig. 4 , Online Methods), a marker of CD8 + TEM cells 34 , enabling direct comparison of gene expression between similar subsets. We identified a similar complement of genes that were highly expressed in TEM cells from each tissue compared to blood ( Fig. 3a-c) . Interestingly, these tissue-intrinsic genes include those associated with microtubules and the cytoskeleton (tubulin-encoding genes TUBA1A, TUBA1B, TUBB, TUBB4B; S100A4) and genes encoding cell matrix, membrane scaffolding, and adhesion molecules (VIM or vimentin, galectins LGALS1/LGALS3, AMICA1, ITM2C, EZR, annexins ANXA1/ANXA2) ( Fig. 3a-c) . TRM signature genes including ITGA1 and ITGAE were also upregulated in tissues compared to blood, particularly in the lung (Fig. 3a-c) . These findings suggest that localization of T cells in tissues likely involves structural changes in the cell that facilitate interactions with tissue matrix.
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We compared the single-cell distribution of average expression of tissue signature genes in the blood and three tissues (Fig. 3d) . CCL5 + TEM cells from all three tissues (both donors) express higher levels of tissue signature genes compared to blood, though LG and LN T cells have higher expression than those from BM (Fig, 3d) . Notably, a minute fraction of blood TEM cells (<0.5%) express this tissue signature at levels comparable to that in LN (within one standard deviation of the mean for all tissues). Shown in a heat map are the relative expression levels for genes within the tissue signature including TRM signature genes 13 cytoskeletal, cellmatrix interactions, cell division, apoptotic, and signaling genes (Fig. 3e) . Gene expression is highest in LG followed by LN and BM expressing only a subset of tissue-associated genes; the outlier subpopulation from blood expresses a fraction (<40%) of tissue signature genes at levels comparable to those in tissues (Fig. 3e) . Together, these results show that tissue T cells express genes associated with infiltration and localization in tissues along with residency markers, while blood contains only trace numbers of cells expressing these genes.
Defining functional states common to blood and tissue T cells
The clustering analysis above suggested that activated T cells were more similar across sites than resting counterparts. To uncover gene expression patterns that were conserved across T cell populations in different tissues, we applied a new analytical method called single-cell
Hierarchical Poisson Factorization (scHPF) 35 . 37, 38 , and AQP3, which encodes a water channel protein of unclear function in lymphocytes 39 . Importantly, the CD4 + /CD8 + Resting module did not contain factors from blood and had the highest enrichment for the tissue signature identified in Fig. 3 (Supplementary Fig.   6 ).
There were four modules associated with T cell activation and/or function, some of which were lineage-specific. A Proliferation module expressed by activated CD4 + and CD8 + lineages included genes associated with T cell activation/proliferation (IL2, LIF) and cell division (CENPV, G0S2, ORC6) (Fig. 4a ). This module was also marked by expression of NME1, a metastasis suppressor/endonuclease-encoding gene 40 not previously associated with T cells (Fig.   4a ). the Cytotoxic module was expressed among resting and activated cells (Fig. 4e) . Therefore, scHPF takes an unbiased approach to uncover major functional states, reference signatures and activation trajectories for human T cells that are conserved across sites.
CD4 + T cell activation states result from distinct responses to TCR and type II IFN signaling
The functional states identified for human CD8 + T cells in Fig. 4 were consistent in with those seen in vivo in mouse infection models 15 . By contrast, the modules identified for CD4 + T cell activation revealed markers and functional states not typically associated with effector by TCR-mediated activation, as well as that induced by culture with IFN-γ ( The study of healthy human T cells has largely focused on blood, while the majority of T cells persist in diverse lymphoid, mucosal and barrier sites 8, 57 . Human tissue T cells are largely memory subsets, comprising tissue-resident (TRM) and non-resident (TEM, TCM) populations;
TRM predominate in mucosal sites, while TEM are found in spleen, LN and BM 13, 33, 58 . The relationship of these tissue-localized TEM to blood TEM has been unclear. Profiling using scRNAseq enabled unambiguous assessment of T cell-intrinsic differences in tissue versus blood T cells. We show that TEM from all sites examined (LG, LN, BM) exhibit fundamental changes in expression of cytoskeletal, cell-matrix interaction, and proliferative genes, indicating alterations in cellular structure. These tissue-intrinsic expression patterns are distinct from previously identified TRM-associated genes 13 , and are lowly expressed in T cells from blood.
Whether T cells require these markers to localize within the tissue architecture, and/or their loss of expression enables egress to circulation remains to be established. 
Isolation and Stimulation of T cells for Single-Cell RNA-seq
Tissues acquired from donors were maintained in cold saline during transport to the laboratory, typically within 2-4 hours of procurement. We isolated mononuclear cells from donor lungs, lung lymph nodes and bone marrow as previously described 11, 63 . Briefly, we flushed the left lobe of the lungs with cold complete medium (RPMI 1640, 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine) and isolated lymph nodes from the hilum, near the intersections of major bronchi and pulmonary veins and arteries, removing all fat. To obtain mononuclear cell suspensions, hilar lymph nodes and the left lateral basal segment of the lung were mechanically processed using a gentleMACS tissue dissociator (Miltenyi Biotec), enzymatically digested (complete medium with 1 mg/ml collagenase D, 1 mg/ml trypsin inhibitor and 0.1 mg/ml DNase for 1 hour at 37°C in a mechanical shaker) and centrifuged on a density gradient using 30% Percoll Plus (GE Healthcare). We aspirated bone marrow from near 
Single-Cell RNA-seq
We loaded single-cell suspensions into a Chromium Single Cell Chip Table 2. 2 0
Single-Cell RNA-seq Data Processing
Prior to gene expression analysis, we corrected the raw sequencing data for index swapping, a phenomenon that occurs during solid-phase clonal amplification on the Illumina HiSeq 4000
platform and results in cross-talk between sample index sequences. We corrected index swapping using the algorithm proposed by Griffiths et al 64 . First, we aligned the reads associated with each sample index to GRCh38 (GENCODE v.24) using STAR v.2.5.0 after trimming read 2 to remove 3' poly(A) tails (> 7 A's) and discarding fragments with fewer than 24 remaining nucleotides as described in Yuan et al 65 .
For each read with a unique, strandspecific alignment to exonic sequence, we constructed an address comprised of the cellidentifying barcode, unique molecular identifier (UMI) barcode, and gene identifier. Next, we counted the number of reads associated with each address in each sample. Because of index swapping, we found that some addresses occurred in multiple samples at much higher frequencies than one would expect by chance. For the vast majority of addresses, there was a single sample containing most of the associated reads. If >80% of reads for a given address were associated with a single sample (e.g. a single index sequence), we kept all of the reads corresponding to that address in that sample and removed all of the reads associated with that address from all other samples 64 . We also identified addresses for which no sample contained >80% of the corresponding reads and removed all of these reads from all samples. After correcting for index swapping, we collapsed amplification duplicates using the UMIs and corrected errors in both the cell-identifying and UMI barcodes to generate a preliminary matrix of molecular counts for each cell as described previously 65 .
We filtered the cell-identifying barcodes to avoid dead cells and other artifacts as described in Yuan et al 65 .
Briefly, we removed all cell-identifying barcodes where >10% of molecules aligned to genes expressed from the mitochondrial genome or for which the ratio of 2 1 molecules aligning to whole gene bodies (including introns) to molecules aligning exclusively to exons was >1.5. Finally, we also removed cell-identifying barcodes for which the average number of reads per molecule or average number of molecules per gene deviated by >2.5 standard deviations from the mean for a given sample.
Computational Identification of T Cells
As described above, we used negative selection to experimentally remove as many non-T cells as possible from our single-cell suspensions. This procedure was imperfect, and so all of our samples inevitably contained some non-T cells (average T cell purity was ~80%). Thoroughly removing non-T cells from the data set is complicated by technical issues such as molecular cross-talk, multiplet capture, and a broad coverage distribution. We developed a procedure to remove non-T cells that accounts for these issues by identifying both individual cells and clusters of cells that are enriched in expression of a blacklisted gene set that is highly specific to contaminating cell types.
We began by clustering the single-cell profiles within each sample using a pipeline that we reported previously 65, 66 . Briefly, we identified highly variable genes that are likely markers of specific subpopulations by normalizing the molecular counts for each cell to sum to one, ordering all genes by their normalized expression values, and computing a drop-out score ds g for each gene g defined as:
where f g is the fraction of cells in which we detected g and f g max is the maximum f g in a 25-gene rolling window centered on g. We selected genes with ds g > 0.15 or with ds g > 6σ ds + < ds g >, where σ ds and < ds g > are the standard deviation and mean of the dropout score distribution.
Using these genes, we computed a cell-by-cell Spearman's correlation, from which we
constructed a k-nearest neighbor's graph (k=20) and used this as input for the Phenograph 30 implementation of Louvain clustering to identify cellular subpopulations.
Next, we used the pooled normalization approach described by Lun et al as implemented in the scran package with the computeSumFactors function to compute size factors for each cell 67, 68 .
We supplied the computeSumFactors function with the cluster identifiers obtained from
Phenograph to account for cell type-specific coverage differences. Using the resulting normalized expression profiles, we identified Phenograph clusters with positive enrichment of average CD3D and TRAC expression and labeled these clusters as T cell clusters ( Supplementary   Fig. S1 ). Within each sample, we conducted differential expression analysis between all pairs of T cell and non-T cell clusters via the Wilcoxon rank-sum test using the SciPy function ranksums and Benjamini-Hochberg corrected p-values with the StatsModels function multipletests in Python. Finally, we established an initial blacklist of genes that are highly specific to the non-T cell clusters by taking any gene with p < 0.001 and greater than 10 fold-enrichment in a non-T cell cluster for any of the above pairwise comparisons in any sample. To refine the blacklist and avoid including genes that are specific to T cell subsets found in only a limited set of samples or clusters, we also generated a whitelist of genes with positive enrichment in any T cell cluster. We removed any member of this whitelist from the initial blacklist to produce a final, refined blacklist containing 744 genes highly specific to contaminating cell types (Supplementary Table   3 Fig. 1e ).
The vast majority of cells in the lower mode were in the T cell clusters described above, while the high mode was composed mainly, but not exclusively, of cells from non-T cell clusters ( Supplementary Fig. 1e ). In each sample, we fit a Gaussian to ܾ 's distribution across cells assigned to T cell clusters and established a threshold at two standard deviations above the fitted mean. We considered any cell with ܾ above this threshold and any cell that clustered among the non-T cell clusters to be a non-T cell and discarded these cells from all downstream analysis.
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Course-Grained Clustering of Merged T Cells from Each Donor
Once we had identified the T cells from each sample using the methodology described above, we merged resting and activated samples from all of the tissues in each donor and clustered the T cells from the two donors separately to generate Fig. 1b,c . We used the methodology described above to identify a set of highly variable genes for each sample (including the blood samples), and then merged those sets to generate a large list of 315 highlyvariable genes (Supplementary Table 4 ) with which we clustered the merged samples from both donors. We computed Louvain clusters from the two merged data sets with k = 12 and a minimum cluster size of 100 cells using a k-nearest neighbors graph constructed from the Spearman's correlation matrix calculated using the 315 highly variable genes. We used the Python implementation Uniform Manifold Approximation and Projection (UMAP) 31 to produce the two-dimensional projections shown in Fig. 1b,c . To obtain CD4/CD8 ratios for each cluster, we first computed the expression level of CD4 and CD8A in each cell using the normalized counts from computeSumFactors as described above. For both CD4 and CD8A, we then computed the average log 2 (normalized counts + 1) for each cluster and normalized this value by the average log 2 (normalized counts + 1) for all cells. We then took the log-ratio of these values for CD4 and CD8A to generate Fig. 1b , where all the cells in each cluster are labeled with the cluster's log-ratio.
Blood Projection Analysis
To project the data obtained from blood T cells onto the tissue-derived profiles from each organ donor, we first merged the scRNA-seq profiles from both blood donors. We note that the scRNA-seq data from blood were subjected to the same computational procedure described 2 5 above for eliminating non-T cell profiles. We used the same highly variable gene set (Supplementary Table 4 ) that was used in the original UMAP model of each organ donor to compute a Spearman's correlation matrix between the blood and tissue profiles. We then projected the blood T cell profiles onto the UMAP models for each of the two organ donors using the transform function in UMAP. We note that the organ donor UMAP models used for this analysis are slightly different from what appears in Fig. 1b,c , because a small number of genes in the highly variable gene set were eliminated due to lack of expression in the blood. We also note that a small modification to the UMAP source code was needed to accommodate the use of Spearman's correlation as a similarity metric.
To generate the cell number heatmaps in Fig. 2 and Supplementary Fig. 3 , we first computed a centroid position in the UMAP embedding for each cluster-tissue combination in the tissue data based on the Louvain clustering described above for 
Comparison of Tissue and Blood Effector Memory T Cells
To identify a tissue-specific T cell signatures, we compared the expression profiles of effector memory cells from resting LG, BM, and LN T cells from the two tissue donors to resting blood T cells from the two blood donors. We found CCL5 to be an extremely highly expressed marker of effector memory cells that exhibited strong anti-correlation with SELL, a marker of non-effector 2 6 memory cells, in all of our resting samples ( Supplementary Fig. 4a ). We also found that the average number of reads per molecule for CCL5 was bimodally distributed, consistent with spurious detection of CCL5 in a population of cells due to PCR recombination ( Supplementary   Fig. 4b ). For each sample, we used the point between these two modes where the probability density was minimal as a threshold for the minimum average number of reads per molecule of CCL5 required for a cell to be considered positive for CCL5. 
Hochberg corrected p-values with the StatsModels function multipletests in Python after
removing genes from the blacklist described above (Supplementary Table 3) . For each tissue, we took all genes with p adj < 0.05 and fold-change > 2 in all four pairwise comparisons to comprise a tissue-specific effector memory T cell signature (Fig. 3) .
Next, all of the genes in the tissue-specific effector memory T cell signature and computed the average normalized expression of the resulting gene set to obtain Fig. 3d . Z-scored normalized expression for each of these genes appears in the heatmap in Fig. 3e for each site / donor, which also includes a set of blood T cells with outlier expression of the tissue-enriched gene signature (blood T cells with average expression within one standard deviation of that of the tissue T cells as indicated by the dashed line in Fig. 3d ).
Single-cell Hierarchical Poisson Factorization and Transcriptional Module Analysis
We applied Single-cell Hierarchical Poisson Factorization (scHPF), a method that we recently reported for de novo discovery of gene expression signatures in scRNA-seq data, to the merged 2 7 activated and resting cells for each tissue and donor 66 . Given a molecular count matrix, scHPF identifies a small number of latent factors that explain both continuous and discrete expression patterns across cells. Each gene has a score for each factor, quantifying the gene's contribution to the associated expression pattern. Likewise, each cell assigns a score to each factor, which reflects the contribution of the factor to the observed expression in the cell.
We applied scHPF to each tissue and blood sample after merging their respective resting and activated datasets. We considered only genes with GENCODE protein coding, T cell receptor constant or immunoglobulin constant biotypes, excluded genes on the previously described blacklist, and removed genes detected in fewer than 0.1% of cells in a given merged Fig. 5 ). This resulted in eight factorizations: six from tissue donors (lung, bone marrow, and lymph node from each of two organ donors) and two factorizations from the blood of living donors. We defined each factors' CD4/CD8 bias as the log2 ratio of its mean cell score in CD4 + and CD8 + T cells.
To discover common patterns of expression across tissues and donors, we performed unsupervised clustering of all factors for tissue-derived cells. First, we calculated Pearson correlation on the union of the fifty highest and lowest scoring genes in each factor for each 2 8 tissue factorization (2,291 genes total) using the Python pandas package's DataFrame.corr function. Next, we hierarchically clustered the factor-factor correlation matrix using scipy.cluster.hierarchy.linkage with method='average' and scipy.cluster.hierarchy.dendrogram (Extended Data Fig. 4 ). This defined clusters of tightly correlated expression patterns, which we call expression modules. We focused on seven modules (out of nine) whose factors had mean pairwise correlations greater than 0.25. Most modules contained at least one factor from each tissue and donor. To identify the top genes in each module (Fig. 4a, Supplementary Table 7 ), we ranked genes by their mean gene score across all constituent factors. Finally, we noticed that the CD4 IFN response module contained two factors from Donor 2's bone marrow; however, one of the two factors was far more tightly correlated with the rest of the factors in the module than the other. As the top genes in the module were nearly identical with and without the less tightlycorrelated factor, we excluded it from the module in downstream analyses for clarity.
Activation Trajectory Analysis
We used the factorizations described above to compute T cell activation trajectories by diffusion component analysis. We first converted the cell score matrix obtained from the factorization of each resting/activated merged tissue or blood sample into a cell-by-cell Euclidean distance matrix. We then extracted the distance submatrices corresponding to the CD4 and CD8 clusters in each sample as defined from the merged analysis of all samples from each donor described above. We used the two resulting distance submatrices to compute diffusion components for CD4 and CD8 activation with the C++ Accelerated Python Diffusion Maps Library (DMAPS) with a kernel bandwidth of four. The diffusion maps shown in Fig. 4b -e each show the first two diffusion components which we define as the two diffusion eigenvectors with the second-and third-highest eigenvalues scaled by the diffusion eigenvector with the largest eigenvalue. The results are summarized in Supplementary Fig. 2 and the gating strategy is shown in Supplementary Fig. 9 .
Gene Expression Kinetics by Quantitative Real-Time PCR
We isolated mononuclear cells from peripheral blood, magnetically enriched for CD3+ T cells, 
Tumor-Associated T Cell Projection Analysis
We projected scRNA-seq profiles of tumor-associated T cells from four different tumor types onto a UMAP embedding of resting and activated T cells from across our combined tissue and blood data set using the methods described above for projecting blood T cells onto embeddings of the tissues. Briefly, we used the highly variable gene set from Supplementary Table 4 to generate a UMAP embedding of our tissue/blood data set from a Spearman's correlation matrix.
We then projected the tumor-associated T cell profiles onto this embedding using the transform function in UMAP. Tumor-associated T cells from non-small cell lung cancer (NSCLC) 49 and breast cancer (BC) 48 , which were profiled using the 10x Genomics Chromium platform, were obtained from https://gbiomed.kuleuven.be/scRNAseq-NSCLC and GEO accession 3 1 GSE114724 (samples BC09, BC10, and BC11), respectively. For these two data sets, we used the UMI-corrected molecular counts provided by the authors. T cells from colorectal cancer (CRC) 47 and melanoma (MEL) 27 , which were profiled using SMART-seq, were obtained from GEO accessions GSE108989 and GSE120575 (pre-treated samples only). For these two data sets, we used the TPM values provided by the authors. We note that the tissue/blood embedding was re-computed for each projection and is therefore slightly different in each case because not all of the processed data sets from the tumor studies contained all of the genes in Supplementary   Table 4 .
The resulting projections are displayed in Fig. 6 in three different ways. In the top row, the projections are displayed as contour plots of estimated probability density (kernel density estimates) with a maximum of 14 contours. In the second row, we used a hexbin two- 
Data Availability
The scRNA-seq data are available on the Gene Expression omnibus (GEO) under accession number GSE126030.
Code Availability
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